Evidence map›Paper›PMID 32320442›Full record

ArticlePLoS pathogens2020

Role for the shelterin protein TRF2 in human herpesvirus 6A/B chromosomal integration.

Shella Gilbert-Girard, Annie Gravel, Vanessa Collin, Darren J Wight, Benedikt B Kaufer, Eros Lazzerini-Denchi, Louis Flamand

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Evasion of the Host Immune Response by Betaherpesviruses.International journal of molecular sciences · 2021
    Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Shella Gilbert-GirardDivision of Infectious Disease and Immunity, CHU de Québec Research Center, Quebec City, Quebec, Canada.ORCID 0000-0003-2338-5698
Annie GravelDivision of Infectious Disease and Immunity, CHU de Québec Research Center, Quebec City, Quebec, Canada.ORCID 0000-0001-5229-5750
Vanessa CollinDivision of Infectious Disease and Immunity, CHU de Québec Research Center, Quebec City, Quebec, Canada.
Darren J WightInstitut für Virologie, Freie Universität Berlin, Berlin, Germany.ORCID 0000-0001-6320-5597
Benedikt B KauferInstitut für Virologie, Freie Universität Berlin, Berlin, Germany.ORCID 0000-0003-1328-2695
Eros Lazzerini-DenchiLaboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Louis FlamandDivision of Infectious Disease and Immunity, CHU de Québec Research Center, Quebec City, Quebec, Canada.ORCID 0000-0001-5010-4586
Freie Universität Berlin · DENational Institutes of Health · USUniversité Laval · CA

Funding

CIHR MOP_123214CIHR PJT_156118
6 · The paper itself

Abstract

Human herpesviruses 6A and 6B (HHV-6A/B) are unique among human herpesviruses in their ability to integrate their genome into host chromosomes. Viral integration occurs at the ends of chromosomes within the host telomeres. The ends of the HHV-6A/B genomes contain telomeric repeats that facilitate the integration process. Here, we report that productive infections are associated with a massive increase in telomeric sequences of viral origin. The majority of the viral telomeric signals can be detected within viral replication compartments (VRC) that contain the viral DNA processivity factor p41 and the viral immediate-early 2 (IE2) protein. Components of the shelterin protein complex present at telomeres, including TRF1 and TRF2 are also recruited to VRC during infection. Biochemical, immunofluorescence coupled with in situ hybridization and chromatin immunoprecipitation demonstrated the binding of TRF2 to the HHV-6A/B telomeric repeats. In addition, approximately 60% of the viral IE2 protein localize at cellular telomeres during infection. Transient knockdown of TRF2 resulted in greatly reduced (13%) localization of IE2 at cellular telomeres (p<0.0001). Lastly, TRF2 knockdown reduced HHV-6A/B integration frequency (p<0.05), while no effect was observed on the infection efficiency. Overall, our study identified that HHV-6A/B IE2 localizes to telomeres during infection and highlight the role of TRF2 in HHV-6A/B infection and chromosomal integration.

Indexed as

Cell Line, TumorDNA-Binding ProteinsDNA, ViralHerpesvirus 6, HumanHumansImmediate-Early ProteinsRoseolovirus InfectionsShelterin ComplexTelomereTelomere-Binding ProteinsTelomeric Repeat Binding Protein 2Viral ProteinsVirus IntegrationVirus ReplicationDNA-Binding ProteinsDNA, ViralImmediate-Early Proteinsp41 protein, Human herpesvirus 6Shelterin ComplexTelomere-Binding ProteinsTelomeric Repeat Binding Protein 2TERF2 protein, humanU95 protein, human herpesvirus 6BViral Proteins

Identifiers

PMID32320442
PMCPMC7197865
OpenAlexW3016536134

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.